Skip to content
value.today
Total raised
$2 M
1 round on record
Latest round
$2 M
Jan 2010
First round on record
Jan 2010
Today
Private
See the company page

GenVec Inc. is listed today as GenVec: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of GenVec Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Jan 2010$2 MNo. 1$2 to $10 million

GenVec Inc.: Raise no. 1, Jan 2010

Investors in this round

1 investor had bought by the notice of Jan 28, 2010: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$2 M of $2 M offered
Smallest investment taken
$1,999,999
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
$5 million to $25 million
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Douglas J. Swirsky · Executive Officer
  • Paul H. Fischer · Director, Executive Officer
  • Joshua M. Ruch · Director
  • Kevin M. Rooney · Director
  • Marc M. Schneebaum · Director
  • Wayne T. Hockmeyer · Director
  • William N. Kelley · Director
  • Zola P. Horovitz · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Douglas J. Swirsky, Senior Vice President and Chief Financial Officer. Source: SEC Form D, newest notice filed Jan 28, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • GenVec Inc. had revenue between $5 million and $25 million when it filed its newest notice of a funding round (Jan 2010).

    SEC Form D (revenue range) · Jan 2010

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Jan 2010

Products and services#

No products or services of GenVec Inc. are on record.

Investors#

No investor of GenVec Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 1 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by GenVec Inc.
NameRoleNamed in
Douglas J. SwirskyExecutive officerJan 2010
Paul H. FischerExecutive officerJan 2010
Joshua M. RuchDirectorJan 2010
Kevin M. RooneyDirectorJan 2010
Marc M. SchneebaumDirectorJan 2010
Paul H. FischerDirectorJan 2010
Wayne T. HockmeyerDirectorJan 2010
William N. KelleyDirectorJan 2010
Zola P. HorovitzDirectorJan 2010